Predict your next investment

Binx Health company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
mybinxhealth.com

See what CB Insights has to offer

Total Raised

$203.5M

Investors Count

20

Deal Terms

2

Binx Health Funding, Binx Health Valuation & Binx Health Revenue

8 Fundings

Binx Health's latest funding round was a Series E for $104M on May 27, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/27/2021

Series E

$104M

2

11/10/2020

Series D - II

$99M

10

1/23/2017

Series D

$99M

10

1/29/2015

Series C

$99M

10

4/29/2014

Series B - II

10

Date

5/27/2021

11/10/2020

1/23/2017

1/29/2015

4/29/2014

Round

Series E

Series D - II

Series D

Series C

Series B - II

Amount

$104M

$99M

$99M

$99M

Investors

Valuation

Revenue

Sources

2

10

10

10

10

Binx Health Deal Terms

2 Deal Terms

Binx Health's deal structure is available for 2 funding rounds, including their Series B from July 20, 2011.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Binx Health Investors

20 Investors

Binx Health has 20 investors. Life Sciences Partners invested in Binx Health's Series E funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/20/2011

5/27/2021

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)

Venture Capital

Netherlands

7/20/2011

5/27/2021

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)

Corporate Venture

New Jersey

11/10/2020

5/27/2021

2
Series D - II, Series E (2021)

Venture Capital

Spain

00/00/0000

00/00/0000

Parian Global Management

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

ArrowMark Partners

Subscribe to see more

Asset/Investment Management

Colorado

First funding

7/20/2011

7/20/2011

11/10/2020

00/00/0000

00/00/0000

Last Funding

5/27/2021

5/27/2021

5/27/2021

00/00/0000

00/00/0000

Investor

Parian Global Management

ArrowMark Partners

Rounds

5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)
5
Series B, Series B - II (2014), Series C (2015), Series D (2017), Series E (2021)
2
Series D - II, Series E (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporate Venture

Venture Capital

Asset/Investment Management

Asset/Investment Management

Location

Netherlands

New Jersey

Spain

New York

Colorado

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.